J&J to start mid-stage coronavirus vaccine trials in three European countries

Johnson & Johnson’s (JNJ.N) Janssen unit will begin mid-stage trials for its coronavirus vaccine in Spain, the Netherlands and Germany next week, Spain’s health minister said on Friday, as the U.S. drugmaker expands testing for its experimental shot.